Currently Enrolling

BAX DUO Prevent-HF

Phase III Study Investigating the role of Baxdrostat in combination with Dapagliflozin, compared to Dapagliflozin alone, in the incidence of Heart Failure and Cardiovascular Death in participants at increased risk of developing Heart Failure.

Trial Overview

Clinical Area: Heart Failure
Condition: T2 Diabetes Mellitus, Cardiovascular Disease, risk factor for Heart Failure
Trial Identifiers:
Locations:
  • Wesley Testing Centre Milton, Brisbane
  • Shenton House Joondalup, Perth
  • Leabrook, Adelaide

Register Your Interest

Complete the form and a member of our Research & Clinical Trials team will be in touch.

Participate in Ongoing Clinical Trials

Eligible patients may have access to new cardiovascular treatments, monitoring technologies, and research programs through the Advara HeartCare network.







    Your information is kept confidential and used only for trial matching.